Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Hamsa-1 (TL-118)
i
Other names:
TL-118, TL-111, TL-112
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Tiltan Pharma
Drug class:
Alkylating agent, Angiogenesis inhibitor, Histamine H2 receptor antagonist
Related drugs:
‹
cyclophosphamide (66)
trabectedin (24)
STAR-001 (16)
lomustine (15)
carmustine (14)
lurbinectedin (11)
melphalan (9)
chlorambucil (7)
melphalan flufenamide (7)
temozolomide gel (7)
procarbazine hydrochloride (4)
OBI-3424 (4)
D19466 (4)
mitomycin (3)
thiotepa (3)
bendamustine RTD (2)
LP-284 (2)
fotemustine (2)
busulfan (2)
VAL-083 (2)
ACHM-025 (1)
BYON4413 (1)
FGX15-147-based ADC (1)
treosulfan (1)
IMGS-101 (1)
bendamustine rapid infusion (0)
ranimustine (0)
carmustine implant (0)
altretamine (0)
mechlorethamine (0)
satraplatin (0)
PR104 (0)
pegylated liposomal mitomycin-c prodrug (0)
QBS72S (0)
mechlorethamine gel (0)
EX-204 (0)
captisol-enabled melphalan (0)
cyclophosphamide intravenous (0)
D 19575 (0)
CB1954 (0)
SJ-C1044 (2)
VB-111 (2)
SIBP-04 (bevacizumab biosimilar) (1)
E7050 (1)
CM101 (0)
defibrotide (0)
squalamine (0)
ADH-1 (0)
GS-156 (0)
84AA-API 14AA (0)
PB101 (0)
RC402 (0)
IOA-289 (0)
ENV-105 (0)
iMX-110 (0)
ACE-041 (0)
sonepcizumab (0)
PT-112 (0)
PG545 (0)
L19-I131 (0)
rifampicin (0)
LB401 (0)
SU5416 (0)
CB1089 (0)
ABT-510 (0)
cyclophosphamide (66)
trabectedin (24)
STAR-001 (16)
lomustine (15)
carmustine (14)
lurbinectedin (11)
melphalan (9)
chlorambucil (7)
melphalan flufenamide (7)
temozolomide gel (7)
procarbazine hydrochloride (4)
OBI-3424 (4)
D19466 (4)
mitomycin (3)
thiotepa (3)
bendamustine RTD (2)
LP-284 (2)
fotemustine (2)
busulfan (2)
VAL-083 (2)
ACHM-025 (1)
BYON4413 (1)
FGX15-147-based ADC (1)
treosulfan (1)
IMGS-101 (1)
bendamustine rapid infusion (0)
ranimustine (0)
carmustine implant (0)
altretamine (0)
mechlorethamine (0)
satraplatin (0)
PR104 (0)
pegylated liposomal mitomycin-c prodrug (0)
QBS72S (0)
mechlorethamine gel (0)
EX-204 (0)
captisol-enabled melphalan (0)
cyclophosphamide intravenous (0)
D 19575 (0)
CB1954 (0)
SJ-C1044 (2)
VB-111 (2)
SIBP-04 (bevacizumab biosimilar) (1)
E7050 (1)
CM101 (0)
defibrotide (0)
squalamine (0)
ADH-1 (0)
GS-156 (0)
84AA-API 14AA (0)
PB101 (0)
RC402 (0)
IOA-289 (0)
ENV-105 (0)
iMX-110 (0)
ACE-041 (0)
sonepcizumab (0)
PT-112 (0)
PG545 (0)
L19-I131 (0)
rifampicin (0)
LB401 (0)
SU5416 (0)
CB1089 (0)
ABT-510 (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login